Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.30 |
| ▸ | UCHL3 | P15374 | 1/20 | 0.30 |
| ▸ | ECE1 | P42892 | 1/20 | 0.30 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7326908 | 0.95 | MEN1 (0.33) | ALDH1A1TSHRMEN1LMNAMAPT | |
| Perchlorobenzene SCHEMBL8872243 | 0.67 | ALDH1A1 (0.50) | ALDH1A1TSHRMEN1LMNAMAPT | |
| Perchlorobenzene SCHEMBL1330781 | 0.67 | ALDH1A1 (0.50) | ALDH1A1TSHRMEN1LMNAMAPT | |
| Perchlorobenzene SCHEMBL26562 | 0.67 | ALDH1A1 (0.50) | ALDH1A1TSHRMEN1LMNAMAPT | |
| Perchlorobenzene SCHEMBL27479713 | 0.61 | ALDH1A1 (0.46) | ALDH1A1TSHRMEN1LMNAMAPT | |
| Perchlorobenzene SCHEMBL27572457 | 0.61 | ALDH1A1 (0.46) | ALDH1A1TSHRMEN1LMNAMAPT | |
| Perchlorobenzene SCHEMBL28193509 | 0.61 | ALDH1A1 (0.46) | ALDH1A1TSHRMEN1LMNAMAPT | |
| Perchlorobenzene SCHEMBL11319188 | 0.61 | ALDH1A1 (0.46) | ALDH1A1TSHRMEN1LMNAMAPT | |
| Perchlorobenzene SCHEMBL28065701 | 0.61 | ALDH1A1 (0.46) | ALDH1A1TSHRMEN1LMNAMAPT | |
| Perchlorobenzene SCHEMBL27972002 | 0.61 | ALDH1A1 (0.46) | ALDH1A1TSHRMEN1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100240713-A1 | AROMATIC AND HETEROAROMATIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS | XENON PHARMACEUTICALS INC. (CA) | 2010-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240713-A1 | AROMATIC AND HETEROAROMATIC COMPOUNDS USEFUL IN TREATING IRON DISORDERS | SLC40A1, PAH, FECH | ALDH1A1 749/4885TSHR 623/4885MEN1 933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.